Title: Retrospective Evaluation of Adverse Reactions Associated with Blood Transfusions Reported in the Blood Banks of Kerala

Authors: P. K. Sreekumar, T. M. Pramod Kumar, G. Partha Sarathi, Debasish Gupta, Pallavi

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i3.87

Abstract

A retrospective review of all the adverse transfusion reactions reported from 01/01/2014 to 31/12/2015 by the 19 blood banks of Kerala was done with the aim to assess the frequency and type of transfusion reactions occurring in patients receiving blood transfusion. During the study period a total of 455201 units of blood products were issued from the subjected blood banks for transfusion. RBC is the major product (39.8%) issued for transfusion and under the hemovigilance system, totally 814 adverse reactions (0.18%) were reported during the study period. Among them, the most common type of reaction observed was febrile non-hemolytic transfusion reaction (FNHTR) 69.9% (n =569) followed by anaphylaxis, Post transfusion purpura (PTP), Transfusion associated dyspnoea (TAD) were also reported. No major reactions like transfusion related acute lung injury (TRALI), transfusion associated graft Vs host disease (TAGvHD), transfusion associated circulatory overload (TACO) and haemolysis were reported. No infections were also reported during the study period. From this study it was clear that the frequency of adverse transfusion reactions was 0.18%. Obivesoly, it may be due to an underestimation of the true incidence because of under reporting and it revealed that necessity of awareness development regarding with safe blood transfusion and the implementation of proper and effective haemovigilance system to provide better patient care.

Keywords: Adverse transfusion reaction, Blood transfusion, Haemovigilance.

References

1.      Sanjeev Sharma, Poonam Sharma, Lisa N. Tyler. Transfusion of Blood and Blood Products: Indications and Complications. Am Fam Physician 2011; 83(6): 719-724.

2.      Gita Negi, Dushyant Singh Gaur, Rajveer Kaur. Blood transfusion safety: A study of adverse reactions at the blood bank of a tertiary care center. Adv Biomed Res 2015; 4: 237. Doi: 10.4103/2277 9175.168604

3.      Sreekumar PK, Pramod Kumar TM, Partha Sarathi G, Debasish Gupta, Pallavi. Haemovigilance in India - A Milestone in Transfusion Safety. Int J Health Sci Res 2017; 7 (2): 310-315.

4.      Sreekumar PK, Pramod Kumar TM, Partha Sarathi G, Debasish Gupta, Pallavi. Haemovigilance - Roles and global status in transfusion safety: A Review. Int Res J Pharm 2016; 7(12): 5-7. Doi:  10.7897/2230-8407.0712137

5.      Praveen Kumar, Rakesh ThapliyalPoo-nam CoshicKabita Chatterjee. Retrosp-ective evaluation of adverse transfusion reactions following blood product transfusion from a tertiary care hospital: A preliminary step towards hemovigilance. Asian J Transfus Sci 2013; 7(2): 109-115.

6.      Prasun Bhattacharya, Neelam Marwaha,  Hari Krishan Dhawan, Pallab Roy, Sharma RR. Transfusion - related adverse events at the tertiary care center in North India:                 An institutional hemovigilance effort. Asian J Transfus Sci 2011; 5(2): 164-170.

7.      Arewa OP, Akinola NO, Salawu L. Blood transfusion reactions - Evaluation of 462 transfusions at a tertiary hospital in Nigeria. Afr J Med Med Sci 2009; 38 (2): 143-148.

8.      Chakravarty-Vartak U, Shewale R, Vartak S, Faizal F, Majethia N. Adverse reactions of blood transfusion: A study in a tertiary care hospital. Int J Sci Stud 2016; 4(2): 90-94.

9.      Rajesh Kumar, Manvi Gupta, Varun Gupta, Amarjit Kaur, Sonia Gupta. Acute Transfusion Reactions (ATRs) in Intensive Care Unit (ICU): A Retrospective Study.         J Clin Diagn Res 2014; 8(2): 127–129.  Doi: 10.7860/JCDR/2014/7761.4027

10.  Meena Sidhu, Renu Meenia, Irm Yasmeen, Naveen Akhtar. A study of transfusion related adverse events at a tertiary care centre in North India: An initiative towards hemovigilance. Int J Adv Med 2015; 2(3): 206-210. doi: 10.18203/2349-3933.ijam20150545

11.  Safoorah Khalid, Mohammad Usman, Mohammad Khurshid. Acute transfusion reactions encountered in patients at a tertiary care center. J Pak Med Assoc 2010; 60 (10): 832-836

12.  Michlig C, Vu DH, Wasserfallen JB, Spahn DR, Schneider P, Tissot JD. Three years of haemovigilance in a general university hospital. Transfus Med. 2003; 13 (2): 63–72.

13.   Robillard P, Nawej KI, Jochem K. The Quebec hemovigilance system: Descri-ption and results from the first two years. Transfus Apher Sci. 2004; 31 (2): 111–122. 

Fabiana MC, Ana PH, Yokoyama, Marcia RD, Thiago HC, Maria GA, Mariza AM,    Jose M K. Diagnosis and management of Post-Transfusion Purpura - Case report.   

http://www.bloodjournal.org/content/122/21/4834?sso-checked=true

15.  Badami K.G, Joliffe E, Stephens M. Transfusion-associated dyspnoea – shadow or substance  Vox Sang 2015; 109(2): 197-200.